CMRX — Chimerix Cashflow Statement
0.000.00%
- $801.08m
- $669.44m
- $0.21m
Annual cashflow statement for Chimerix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -43.5 | -173 | 172 | -82.1 | -88.4 |
Depreciation | |||||
Non-Cash Items | 5.35 | 56.9 | -216 | 10.5 | 5.88 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.73 | 16.3 | -3.42 | 2.42 | 7.44 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -36 | -99.9 | -46.9 | -69.1 | -75 |
Capital Expenditures | -0.058 | -0.207 | -0.071 | -0.089 | -0.287 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 64.8 | -43.9 | 70.1 | 70.7 | 71.6 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | 64.7 | -44.1 | 70 | 70.6 | 71.3 |
Financing Cash Flow Items | 0.426 | 109 | 0.667 | 0.308 | 0.2 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.41 | 112 | -12.7 | 0.308 | 7.05 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 30.1 | -31.6 | 10.4 | 1.82 | 3.39 |